FRMPX
Price
$26.33
Change
+$0.25 (+0.96%)
Updated
Jun 6 closing price
Net Assets
222.07M
VEXRX
Price
$103.78
Change
+$1.11 (+1.08%)
Updated
Jun 6 closing price
Net Assets
19.41B
Interact to see
Advertisement

FRMPX vs VEXRX

Header iconFRMPX vs VEXRX Comparison
Open Charts FRMPX vs VEXRXBanner chart's image
Nuveen Small Cap Growth Opp A
Price$26.33
Change+$0.25 (+0.96%)
VolumeN/A
Net Assets222.07M
Vanguard Explorer Adm
Price$103.78
Change+$1.11 (+1.08%)
VolumeN/A
Net Assets19.41B
FRMPX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRMPX vs. VEXRX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRMPX is a Buy and VEXRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.4B vs. FRMPX (222M). VEXRX pays higher dividends than FRMPX: VEXRX (0.54) vs FRMPX (0.00). FRMPX was incepted earlier than VEXRX: FRMPX (30 years) vs VEXRX (24 years). FRMPX (1.35) is less costly to investors than VEXRX (0.33). FRMPX is a more actively managed with annual turnover of: 67.00 vs. VEXRX (35.00). FRMPX has a lower initial minimum investment than VEXRX: FRMPX (3000) vs VEXRX (50000). FRMPX annual gain was more profitable for investors over the last year : 8.71 vs. VEXRX (-4.02). VEXRX return over 5 years is better than : 6.60 vs. FRMPX (5.42).
FRMPXVEXRXFRMPX / VEXRX
Total Expense Ratio1.200.33364%
Annual Report Gross Expense Ratio1.350.33409%
Fund Existence30 years24 years-
Gain YTD-2.832-3.91272%
Front Load6%N/A-
Min. Initial Investment3000500006%
Min. Initial Investment IRAN/AN/A-
Net Assets222M19.4B1%
Annual Yield % from dividends0.000.54-
Returns for 1 year8.71-4.02-217%
Returns for 3 years26.424.83547%
Returns for 5 years5.426.6082%
Returns for 10 years10.8912.1490%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HY41.260.43
+1.05%
Hyster-Yale Inc.
AKRO54.280.34
+0.63%
Akero Therapeutics
VICI31.470.02
+0.06%
VICI Properties
SGHT4.20N/A
N/A
Sight Sciences
MIGI0.57-0.01
-0.96%
Mawson Infrastructure Group